Antiviral Drugs for Varicella-Zoster Virus and Herpes Simplex Virus Infections
Antiviral Drugs for Varicella-Zoster Virus and Herpes Simplex Virus Infections
September 24, 2018 (Issue: 1556)
The recommendations for treatment of varicella-zoster
virus (VZV) and herpes simplex virus (HSV)
infections are listed in tables 1 and 2. Vaccination
against VZV was reviewed in a previous issue.
- Adult immunization. Med Lett Drugs Ther 2018; 60:73.
- J Cohen and J Breuer. Chickenpox: treatment. BMJ Clin Evid 2015; 2015:0192.
- JI Cohen. Clinical practice: herpes zoster. N Engl J Med 2013; 369:255.
- RH Dworkin et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44:S1.
- N Chen et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2014; 2:CD006866.
- JW Gnann Jr. and RJ Whitley. Clinical practice: genital herpes. N Engl J Med 2016; 375:666.
- JB Harris and AP Holmes. Neonatal herpes simplex viral infections and acyclovir: an update. J Pediatr Pharmacol Ther 2017; 22:88.
- B Pasternak and A Hviid. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 2010; 304:859.
- American College of Obstetricians and Gynecologists Committee on Practice Bulletins. ACOG Practice Bulletin. No. 82 June 2007. Management of herpes in pregnancy. Obstet Gynecol 2007; 109:1489.
- F Sahoo et al. Herpes zoster in autologous hematopoietic cell transplant recipients in the era of acyclovir or valacyclovir prophylaxis and novel treatment and maintenance therapies. Biol Blood Marrow Transplant 2017; 23:505.
- SL Spruance et al. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies. Antimicrob Agents Chemother 2003; 47:1072.
- A Wald et al. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding. Sex Transm Dis 2006; 33:529.
- L Corey et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11.
- KA Workowski et al. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64:1.
- SL Spruance et al. Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis. J Am Acad Dermatol 2006; 55:47.
- FY Aoki et al. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2006; 42:8.
- M Abudalu et al. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial. Clin Infect Dis 2008; 47:651.
- CDC. Updated recommendations for use of VariZig – United States, 2013. MMWR Morbid Mortal Wkly Rep 2013; 62:574.
- N Perkins et al. Topical imiquimod treatment of acyclovir-resistant herpes simplex disease: case series and literature review. Sex Transm Infect 2011; 87:292.
- SS Abdool Karim et al. Tenofovir gel for the prevention of herpes simplex virus type 2 infection. N Engl J Med 2015; 373:530.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this article? Gain access below.
Subscribe
Subscriptions to
The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App for iOS, Android, and Kindle Fire
- FREE online per issue CME/CE
Purchase this article:
Title: Antiviral Drugs for Varicella-Zoster Virus and Herpes Simplex Virus Infections
Article code: 1556a
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
